Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Jan 28, 2020 7:50am
423 Views
Post# 30607536

RE:i agree with that Lazer

RE:i agree with that LazerTalking to yourself again.  Pando group starting to panic with such a big drop yesterday.

You guys were talking about partnership back in July, Aug, Sep....before that you wanted people to buy rights offering at $15.21

I encourage investors to look at a three year chart, trending down, down, down.....Ryplazim FDA requested checks have been waiting ~2 years, 4050 nothing in a year.


realstocky wrote:

sp at the moment doesnt mean that much, couple weeks back it moved from +-7$ to 21.50$ intra day....imo that was a leak on the coming riplazym partnership. Share availability is limited, spread is high, this action is good for the people looking to get some shares (few) on the cheap, on news the bump up will be drastic though...i see lmnl this year between 50$-80$. 

 

 

---------------------------------------------------------------------------------------

.``Once it gets low enough, it could get lower even and then raise a bit and lower again after.... but when ryplasim news comes in..... skyrocket to 50$.... the question is not if but when....? Long on LmnL with new management..... success within 5 month.... great deal...````



<< Previous
Bullboard Posts
Next >>